Evaluation of colistin nephrotoxicity and urinary level of kidney injury molecule-1 in hospitalized adult ICU patients

Afsaneh Vazin ¹ , Maryam Malek ¹ , Iman Karimzadeh ¹ *

Cited by CrossRef: 3

1- Wang J, Xiang B, Song X, Que R, Zuo X, Xie Y. Prevalence of polymyxin-induced nephrotoxicity and its predictors in critically ill adult patients: A meta-analysis. World J Clin Cases. 2022;10(31):11466 [Crossref]

2- Jia X, Guo C, Yin Z, Zhang W, Du S, Zhang X. Risk Factors for Acute Kidney Injury Induced by Intravenous Polymyxin B in Chinese Patients with Severe Infection. IDR. 2022;Volume 15:1957 [Crossref]

3- Karimzadeh I, Kane-Gill S, Ma B. Anti-Infective-Associated AKI: A Narrative Review of the Epidemiology, Mechanisms, Risk Factors, Biomarkers, Clinical Course, Monitoring, Prevention, and Therapeutic Strategies. Antibiotics. 2025;14(11):1138 [Crossref]

4- Karimzadeh I, Kane‐Gill S. Novel Kidney Biomarkers and Antibiotics‐Induced Acute Kidney Injury: A Practical Assessment of Current and Future Applications. Clinical Translational Sci. 2025;18(12) [Crossref]

5- Deng Y, Gu J, Li X, Tong H, Guo S, Xu B, Li Y, Zhang B, Li Y, Huang H, Xiao G. Does Monitoring Total and Free Polymyxin B1 Plasma Concentrations Predict Polymyxin B-Induced Nephrotoxicity? A Retrospective Study in Critically Ill Patients. Infect Dis Ther. 2022; [Crossref]